152 related articles for article (PubMed ID: 24092763)
21. LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples.
Schmidt H; Schmidt R; Geisslinger G
Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):162-70. PubMed ID: 17085324
[TBL] [Abstract][Full Text] [Related]
22. Erythrocytes store and release sphingosine 1-phosphate in blood.
Hänel P; Andréani P; Gräler MH
FASEB J; 2007 Apr; 21(4):1202-9. PubMed ID: 17215483
[TBL] [Abstract][Full Text] [Related]
23. Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
Becker S; Kinny-Köster B; Bartels M; Scholz M; Seehofer D; Berg T; Engelmann C; Thiery J; Ceglarek U; Kaiser T
PLoS One; 2017; 12(3):e0174424. PubMed ID: 28334008
[TBL] [Abstract][Full Text] [Related]
24. Fatty acids and sphingolipids profile in the blood plasma of experienced divers in response to hyperbaric exposure.
Chabowska AM; Radziwon BB; Lukaszuk B; Lipska A; Chabowski A; Kaczerska D; Siermontowski P; Radziwon P
Undersea Hyperb Med; 2018; 45():521-529. PubMed ID: 30428241
[TBL] [Abstract][Full Text] [Related]
25. Elevated Plasma Ceramides Are Associated With Higher White Matter Hyperintensity Volume-Brief Report.
Mielke MM; Syrjanen JA; Bui HH; Petersen RC; Knopman DS; Jack CR; Graff-Radford J; Vemuri P
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2431-2436. PubMed ID: 31510790
[TBL] [Abstract][Full Text] [Related]
26. Possible involvement of sphingomyelin in the regulation of the plasma sphingosine 1-phosphate level in human subjects.
Ohkawa R; Kurano M; Mishima Y; Nojiri T; Tokuhara Y; Kishimoto T; Nakamura K; Okubo S; Hosogaya S; Ozaki Y; Yokota H; Igarashi K; Ikeda H; Tozuka M; Yatomi Y
Clin Biochem; 2015 Jul; 48(10-11):690-7. PubMed ID: 25863111
[TBL] [Abstract][Full Text] [Related]
27. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure.
Knapp M; Baranowski M; Lisowska A; Musiał W
Adv Med Sci; 2012 Jun; 57(1):100-5. PubMed ID: 22296975
[TBL] [Abstract][Full Text] [Related]
28. Circulating levels of sphingosine-1-phosphate are elevated in severe, but not mild psoriasis and are unresponsive to anti-TNF-α treatment.
Checa A; Xu N; Sar DG; Haeggström JZ; Ståhle M; Wheelock CE
Sci Rep; 2015 Jul; 5():12017. PubMed ID: 26174087
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease.
Sattler KJ; Elbasan S; Keul P; Elter-Schulz M; Bode C; Gräler MH; Bröcker-Preuss M; Budde T; Erbel R; Heusch G; Levkau B
Basic Res Cardiol; 2010 Nov; 105(6):821-32. PubMed ID: 20652276
[TBL] [Abstract][Full Text] [Related]
30. Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients.
Myśliwiec H; Baran A; Harasim-Symbor E; Choromańska B; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
Arch Dermatol Res; 2017 Mar; 309(2):79-86. PubMed ID: 27988894
[TBL] [Abstract][Full Text] [Related]
31. Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes.
Kurano M; Nishikawa M; Kuma H; Jona M; Yatomi Y
PLoS One; 2017; 12(5):e0177543. PubMed ID: 28494002
[TBL] [Abstract][Full Text] [Related]
32. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
33. UPLC-MS/MS method for analysis of sphingosine 1-phosphate in biological samples.
Cutignano A; Chiuminatto U; Petruzziello F; Vella FM; Fontana A
Prostaglandins Other Lipid Mediat; 2010 Sep; 93(1-2):25-9. PubMed ID: 20601074
[TBL] [Abstract][Full Text] [Related]
34. Plasma Sphingolipids are Associated With Gait Parameters in the Mayo Clinic Study of Aging.
Wennberg AMV; Schafer MJ; LeBrasseur NK; Savica R; Bui HH; Hagen CE; Hollman JH; Petersen RC; Mielke MM
J Gerontol A Biol Sci Med Sci; 2018 Jun; 73(7):960-965. PubMed ID: 28977376
[TBL] [Abstract][Full Text] [Related]
35. S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease.
Argraves KM; Sethi AA; Gazzolo PJ; Wilkerson BA; Remaley AT; Tybjaerg-Hansen A; Nordestgaard BG; Yeatts SD; Nicholas KS; Barth JL; Argraves WS
Lipids Health Dis; 2011 May; 10():70. PubMed ID: 21554699
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry.
Lan T; Bi H; Liu W; Xie X; Xu S; Huang H
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Mar; 879(7-8):520-6. PubMed ID: 21292568
[TBL] [Abstract][Full Text] [Related]
37. Cardioprotective role of sphingosine-1-phosphate.
Knapp M
J Physiol Pharmacol; 2011 Dec; 62(6):601-7. PubMed ID: 22314562
[TBL] [Abstract][Full Text] [Related]
38. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry.
Scherer M; Schmitz G; Liebisch G
Clin Chem; 2009 Jun; 55(6):1218-22. PubMed ID: 19325012
[TBL] [Abstract][Full Text] [Related]
39. Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: An observational study.
Buie JNJ; Hammad SM; Nietert PJ; Magwood G; Adams RJ; Bonilha L; Sims-Robinson C
PLoS One; 2019; 14(5):e0216213. PubMed ID: 31067249
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence-based rapid measurement of sphingosine-1-phosphate transport activity in erythrocytes.
Kobayashi N; Otsuka M; Yamaguchi A; Nishi T
J Lipid Res; 2016 Nov; 57(11):2088-2094. PubMed ID: 27655910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
